New Jersey 2024-2025 Regular Session

New Jersey Assembly Bill A911

Introduced
1/9/24  

Caption

Requires institutions of higher education to maintain supply and develop policy governing use of naloxone hydrochloride nasal spray for opioid overdose emergencies.

Impact

The implications of A911 are significant; it represents a proactive approach to combating the opioid crisis on college campuses. By facilitating access to naloxone and training personnel on its use, the bill aims to reduce the number of fatalities linked to opioid overdoses among students. Institutions are expected to create an accessible and accountable system for administering naloxone, which may ultimately save lives. Moreover, the legislation includes provisions for immunity from liability for those administering the medication, encouraging staff and faculty to take action without fear of legal repercussions.

Summary

Assembly Bill A911 mandates that institutions of higher education in New Jersey maintain a supply of naloxone hydrochloride nasal spray, a medication used to treat opioid overdoses. The bill requires these institutions to develop policies governing the emergency use of naloxone, ensuring that licensed campus medical professionals oversee the program. The legislation aims to enhance campus safety by providing a framework for rapid intervention in the event of an opioid overdose, which is a critical issue especially among young adults in university settings. Each institution must designate trained individuals from their community who can administer naloxone in emergencies, thereby promoting a swift response to potential overdose incidents.

Contention

While the bill is broadly supported as a necessary measure to improve health and safety on campuses, there are potential points of contention. Critics may argue about the sufficiency of training and resources provided to staff and students, expressing concerns over whether the implementation will be consistent or effective across all higher education institutions. Additionally, there may be debate regarding the appropriateness of the role of trained non-medical personnel in administering medical interventions, which could lead to discussions about broader health care policies and the availability of trained medical personnel on campus.

Companion Bills

NJ S2803

Same As Requires institutions of higher education to maintain supply and develop policy governing use of naloxone hydrochloride nasal spray for opioid overdose emergencies.

NJ A1170

Carry Over Requires institutions of higher education to maintain supply of opioid antidotes and permits emergency administration of opioid antidote by campus medical professional or trained employee.

NJ S3287

Carry Over Requires institutions of higher education to maintain supply and develop policy governing use of naloxone hydrochloride nasal spray for opioid overdose emergencies.

NJ A4852

Carry Over Requires institutions of higher education to maintain supply and develop policy governing use of naloxone hydrochloride nasal spray for opioid overdose emergencies.

Similar Bills

NJ A4699

Requires institutions of higher education to have automatic external defibrillator on premises and maintain supply of naloxone hydrochloride.

CA SB234

Opioid antagonists: stadiums, concert venues, and amusement parks.

CA AB2998

Opioid overdose reversal medications: pupil administration.

CA AB19

Pupil health: opioid antagonists.

CA AB3271

Pupil health: opioid antagonists.

CA SB472

Pupil health: opioid overdose reversal medication.

CA AB1915

Pupil health: drug education: opioid overdose training program.

ME LD1728

An Act to Ensure Access to Federally Approved Opioid Overdose-reversing Medication